COVID-19: Drug Targets and Potential Treatments
The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Abstract
Currently, humans are immersed in a pandemic caused by the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which threatens public health worldwide. To date, no drug or vaccine has been approved to treat the severe disease caused by this coronavirus, COVID-19. In this paper, we will focus on the main virus-based and host-based targets that can guide efforts in medicinal chemistry to discover new drugs for this devastating disease. In principle, all CoV enzymes and proteins involved in viral replication and the control of host cellular machineries are potentially druggable targets in the search for therapeutic options for SARS-CoV-2. This Perspective provides an overview of the main targets from a structural point of view, together with reported therapeutic compounds with activity against SARS-CoV-2 and/or other CoVs. Also, the role of innate immune response to coronavirus infection and the related therapeutic options will be presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–243 of 243
Therapeutic uses of furin and its inhibitors: a patent review
Couture, F., Kwiatkowska, A., Dory, Y. L., & Day, R. W. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.1000303 · Cited by 90
Kobayashi, Y. O., & Suzuki, Y. (2012) · Journal of Virology · doi:10.1128/jvi.06147-11 · Cited by 89
Dahms, S. O., Arciniega, M., Steinmetzer, T., Huber, R., & Than, M. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613630113 · Cited by 88
X-ray Structures of Human Furin in Complex with Competitive Inhibitors
Dahms, S. O., Hardes, K., Becker, G. L., Steinmetzer, T., Brandstetter, H., & Than, M. E. (2014) · ACS Chemical Biology · doi:10.1021/cb500087x · Cited by 87
RNA synthetic mechanisms employed by diverse families of RNA viruses
McDonald, S. M. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1164 · Cited by 87
Jauregui, A. R., Savalia, D., Lowry, V. K., Farrell, C. M., & Wathelet, M. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062416 · Cited by 86
Wada, Y., Cardinale, I. R., Khatcherian, A., Chu, J., Kantor, A. B., Gottlieb, A. B., Tatsuta, N., Jacobson, E. W., Barsoum, J., & Krueger, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035069 · Cited by 85
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID ‐19
Rothlin, R. P., Vetulli, H. M., Duarte, M., & Pelorosso, F. G. (2020) · Drug Development Research · doi:10.1002/ddr.21679 · Cited by 85
Early events of SARS coronavirus infection in vero cells
Ng, M. L., Tan, S., See, E., Ooi, E. E., & Ling, A. E. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10499 · Cited by 81
Endosomal Maturation, Rab7 GTPase and Phosphoinositides in African Swine Fever Virus Entry
Cuesta-Geijo, M. A., Galindo, I., Hernáez, B., Quetglas, J. I., Dalmau-Mena, I., & Alonso, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048853 · Cited by 80
Self-citationTwo-Pore Channels: Catalyzers of Endolysosomal Transport and Function
Grimm, C. M., Chen, C., Wahl‐Schott, C., & Biel, M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00045 · Cited by 80
Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers
Penny, C. J., Vassileva, K., Jha, A., Yuan, Y., Chee, X., Yates, E., Mazzon, M., Kilpatrick, B. S., Muallem, S., Marsh, M., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.10.022 · Cited by 79
Ramasamy, S., Sáez, B., Mukhopadhyay, S., Ding, D., Ahmed, A. M., Chen, X., Pucci, F., Yamin, R., Wang, J., Pittet, M. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511380113 · Cited by 76
Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome
Rao, S., Gurbani, D., Du, G., Everley, R. A., Browne, C. M., Chaikuad, A., Tan, L., Schröder, M., Gondi, S. R., Ficarro, S. B., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.02.021 · Cited by 71
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Cheng, J., Zhao, Y., Xu, G., Zhang, K., Jia, W., Sun, Y., Zhao, Y., Xue, J., Hu, Y., & Zhang, G. (2019) · Viruses · doi:10.3390/v11100972 · Cited by 68
Ikonomov, O., Sbrissa, D., & Shisheva, A. (2009) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2009.03.063 · Cited by 67
What we know but do not understand about nidovirus helicases
Lehmann, K. C., Snijder, E. J., Posthuma, C. C., & Gorbalenya, A. E. (2014) · Virus Research · doi:10.1016/j.virusres.2014.12.001 · Cited by 67
Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function
Wang, B., Wang, Y., Frabutt, D. A., Zhang, X.-H., Yao, X., Hu, D., Zhang, Z., Liu, C., Zheng, S., Xiang, S.-H., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.768168 · Cited by 65
Cai, W., Li, Y., Chen, S., Wang, M., Zhang, A., Zhou, H., Chen, H., & Jin, M. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.03.008 · Cited by 62
Mahlakõiv, T., Ritz, D., Mordstein, M., DeDiego, M. L., Enjuanes, L., Müller, M. A., Drosten, C., & Staeheli, P. (2012) · Journal of General Virology · doi:10.1099/vir.0.046284-0 · Cited by 62
Verdonck, S., Pu, S., Sorrell, F. J., Elkins, J. M., Froeyen, M., Gao, L., Prugar, L. I., Dorosky, D. E., Brannan, J. M., Barouch‐Bentov, R., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00136 · Cited by 62
NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2
Xu, P., Ye, S., Li, K., Huang, M., Wang, Q., Zeng, S., Chen, X., Gao, W., Chen, J., Zhang, Q., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1448-9 · Cited by 62
Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies
Chaikuad, A., Keates, T., Vincke, C., Kaufholz, M., Zenn, M., Zimmermann, B., Gutiérrez, C., Zhang, R.-G., Hatzos-Skintges, C., Joachimiak, A., et al. (2014) · Biochemical Journal · doi:10.1042/bj20131399 · Cited by 60
Jin, X., Xu, K., Jiang, P., Lian, J., Hao, S., Yao, H., Jia, H., Zhang, Y., Zheng, L., zheng, N., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1781551 · Cited by 60
Kim, M. K., Yu, M.-S., Park, H., Kim, K. B., Lee, C., Cho, S. Y., Kang, J., Yoon, H., Kim, D., Choo, H., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.005 · Cited by 59
Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry
Qiu, S., Leung, A., Bo, Y., Kozak, R. A., Anand, S. P., Warkentin, C., Salambanga, F. R. D., Cui, J. Y., Kobinger, G., Kobasa, D., et al. (2017) · Virology · doi:10.1016/j.virol.2017.09.028 · Cited by 57
Lee, C., Lee, J., Lee, N., Jin, B.-S., Jang, K., Kim, D., Jeong, Y., & Chong, Y. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.010 · Cited by 56
The Serine/Threonine Kinase AP2-Associated Kinase 1 Plays an Important Role in Rabies Virus Entry
Wang, C., Wang, J., Shuai, L., Ma, X., Zhang, H., Liu, R., Chen, W., Wang, X., Ge, J., Wen, Z., et al. (2019) · Viruses · doi:10.3390/v12010045 · Cited by 52
Guo, C., Li, B., Ma, H., Wang, X., Cai, P., Yu, Q., Zhu, L., Jin, L., Jiang, C., Fang, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.08.029769 · Cited by 50
On the structure and mechanism of two‐pore channels
Kintzer, A. F., & Stroud, R. M. (2017) · FEBS Journal · doi:10.1111/febs.14154 · Cited by 47
Transcriptional Inhibition of Host Viral Entry Proteins as a Therapeutic Strategy for SARS-CoV-2Preprint
Wang, X., Dhindsa, R. S., Povysil, G., Zoghbi, A. W., Motelow, J. E., Hostyk, J. A., & Goldstein, D. B. (2020) · Preprints.org · doi:10.20944/preprints202003.0360.v1 · Cited by 44
Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor
Dahms, S. O., Jiao, G., & Than, M. E. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00633 · Cited by 37
Optimization of Substrate‐Analogue Furin Inhibitors
Ivanova, T., Hardes, K., Kallis, S., Dahms, S. O., Than, M. E., Künzel, S., Böttcher‐Friebertshäuser, E., Lindberg, I., Jiao, G., Bartenschlager, R. F. W., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700596 · Cited by 35
Hu, X.-P., Shao, M.-M., Song, X., Wu, X., Qi, L., Zheng, K., Fan, L., Liao, C., Li, C., He, J., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.07.019 · Cited by 32
Dahms, S. O., Hardes, K., Steinmetzer, T., & Than, M. E. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01124 · Cited by 32
Cheng, W., Chen, S., Rui-ling, L., Chen, Y. Z., Wang, M., & Guo, D. (2015) · Virologica Sinica · doi:10.1007/s12250-015-3581-8 · Cited by 30
Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2Preprint
Kang, Y.-L., Chou, Y.-Y., Rothlauf, P. W., Liu, Z., Soh, T. K., Cureton, D., Case, J. B., Chen, R. E., Diamond, M. S., Whelan, S. P. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.21.053058 · Cited by 30
Huang, S., Lee, T.-Y., Lin, Y.-J., Wan, L., Lai, C., & Lin, C. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.07.002 · Cited by 23
Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection
Leber, A. J., Bassaganya-Riera, J., Tubau‐Juni, N., Zoccoli-Rodriguez, V., Lu, P., Godfrey, V., Kale, S. D., & Hontecillas, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00178 · Cited by 21
Structural Basis for the Inhibition of Cyclin G‐Associated Kinase by Gefitinib
Ohbayashi, N., Murayama, K., Kato-Murayama, M., Kukimoto‐Niino, M., Uejima, T., Matsuda, T., Ohsawa, N., Yokoyama, S., Nojima, H., & Shirouzu, M. (2018) · ChemistryOpen · doi:10.1002/open.201800177 · Cited by 19
Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors
Sartori, G., Leitão, A., Montanari, C. A., & Laughton, C. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222055 · Cited by 13
Cited by
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Structural insights into SARS-CoV-2 proteins
Arya, R., Kumari, S., Pandey, B., Mistry, H., Bihani, S. C., Das, A., Prashar, V., Gupta, G. D., Panicker, L., & Kumar, M. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.11.024 · Cited by 348
Structural biology of SARS-CoV-2: open the door for novel therapies
Yan, W., Zheng, Y., Zeng, X., He, B., & Cheng, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00884-5 · Cited by 291
Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Muhammed, M. T., & Aki-Yalcin, E. (2024) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220922103109 · Cited by 267
Barh, D., Tiwari, S., Weener, M. E., Azevedo, V., Góes-Neto, A., Gromiha, M. M., & Ghosh, P. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104051 · Cited by 90
Metadata
- Authors
- Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., & Martinez, A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-06-08
- Volume
- 63
- Issue
- 21
- Pages
- 12359-12386
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3033737840
- Cited by
- 445
- References
- 243
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.